Bristlecone Advisors’s LeonaBio Inc LONA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-25,220
Closed -$71.9K 296
2025
Q1
$71.9K Sell
25,220
-8,531
-25% -$37.8K 0.01% 306
2024
Q4
$198K Hold
33,751
0.02% 275
2024
Q3
$151K Buy
33,751
+25,220
+296% +$592K 0.01% 286
2024
Q2
$226K Hold
8,531
0.02% 259
2024
Q1
$234K Hold
8,531
0.02% 259
2023
Q4
$207K Hold
8,531
0.02% 262
2023
Q3
$172K Hold
8,531
0.02% 258
2023
Q2
$252K Hold
8,531
0.03% 238
2023
Q1
$213K Sell
8,531
-61,132
-88% -$1.97M 0.02% 254
2022
Q4
$2.21M Sell
69,663
-430
-0.6% -$13.5K 0.27% 80
2022
Q3
$2.08M Hold
70,093
0.27% 76
2022
Q2
$2.14M Sell
70,093
-6,063
-8% -$556K 0.26% 81
2022
Q1
$10.3M Hold
76,156
1.26% 21
2021
Q4
$9.92M Hold
76,156
1.19% 18
2021
Q3
$7.14M Hold
76,156
0.93% 22
2021
Q2
$7.8M Buy
+76,156
New +$13.3M 1.06% 22

Other funds holding LONA

Bristlecone Advisors's LONA Position: Q2 2025 in Review

Bristlecone Advisors sold out of LeonaBio Inc (LONA) in Q2 2025, closing a stake of 25,220 shares — an estimated $71.9K sold.

Bristlecone Advisors first reported a position in LONA in Q2 2021 and held it in 16 quarters. The position peaked at $10.3M in Q1 2022. 50 funds tracked by Wall St. Rank hold LONA as of Q2 2025.

  • Bristlecone Advisors reported no remaining LeonaBio Inc position as of Q2 2025 after selling out during the quarter.
  • Bristlecone Advisors sold 25,220 LeonaBio Inc shares in Q2 2025, an estimated $71.9K.
  • Bristlecone Advisors first reported a position in LeonaBio Inc in Q2 2021 and held it in 16 quarters.
  • Bristlecone Advisors's LeonaBio Inc position peaked at $10.3M in Q1 2022.
  • 50 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2025.

Based on Bristlecone Advisors's 13F filing for Q2 2025, filed 4 Aug 2025.